Invivyd · 3 months ago
Associate Director, Statistical Programming
Invivyd is a company focused on delivering protection from serious viral infectious diseases, particularly COVID-19. The Associate Director of Statistical Programming will lead statistical programming efforts and manage regulatory submissions, ensuring compliance with standards and collaboration with other functions.
BiotechnologyPharmaceuticalTherapeutics
Responsibilities
Lead statistical programming and regulatory submission activities
Manage CROs to meet timelines and expectation of quality
Collaborate with other functions to ensure clarity, accuracy and consistency of case report forms (CRFs), develop and comply with project/study programming standards and specifications according to regulatory guidelines
Create and validate SDTM, ADaM, and TLFs
Create, validate, and document complex and reusable macros for data cleaning, validation, analysis, customized report and graph generation, and integration of data
Write and review the data specification of SDTM and ADaM data sets
Track clinical trial milestones and work with vendors for statistical reporting deliverables
Maintain records for all assigned projects and archiving of trial/project analysis and associated documentation
Understands and performs in accordance with regulatory standards and drug development principles
Responsible for the creation and accuracy of regulatory submission data and clinical summary report package
Qualification
Required
BS in statistics, biostatistics, engineering, computer science or equivalent area with 8+ years of experience in statistical programming within the pharmaceutical industry
Excellent SAS software programming skills, including Base SAS, SAS/STAT, SAS/GRAPH and macro development (SAS certification is required)
Strong understanding of clinical trial processes and statistical programming requirements for regulatory submissions (regulatory submission experience including NDAs/MAAs is required)
Extensive experience in defining and implementing CDISC compliant SDTM and ADaM data and specifications
Must be able to travel to New Haven, CT office at least 1x a month
Preferred
Location: Northeast Preferred
Company
Invivyd
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Funding
Current Stage
Public CompanyTotal Funding
$678.5MKey Investors
Silicon Valley BankRA Capital ManagementGoogle Ventures
2025-11-17Post Ipo Equity· $125M
2025-08-20Post Ipo Equity· $57.5M
2025-04-21Post Ipo Debt· $30M
Recent News
2025-12-24
2025-12-24
Company data provided by crunchbase